This shows the weight loss itself was the key drivernot the drug
Mike Haney: I want to come back to all of those other potential benefits what that means for again that question of who are these for but just to, I'm curious, as I've watched this: we talk about sort of harnessing the satiating hormones
6 Conclusion In conclusion, oxidative stress is involved in AD pathophysiology, therefore there is a strong preclinical rationale to incorporate antioxidative agents, as adjuvant treatment, in the AD pharmacopeia
"Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide." Cell Discovery 10.1 (2024): 77
The individual variables are also examined in the ANOVA table
However, since semaglutide can influence the hormonal environment and potentially reach maternal and fetal tissues via the placenta, most healthcare professionals advise pregnant women or those planning pregnancy to avoid GLP-1 receptor agonists like Ozempic